Triple Agonist 100mg — Verification Report

From Modern Research Peptides · Lot RT082126 · Tested August 2026

← Back to Modern Research Peptides

VialTalk

Verification report

Triple Agonist 100mg

Modern Research Peptides

Score

106.5

Grade

A++

Superlative

Lot RT082126

Tested August 2026

Report ID

d96b1ff6

Test

Method

Result

Status

PurityFull credit

HPLC

99.93%

Full credit

IdentityFull credit

Mass spectrometry

Confirmed

Full credit

ContentFull credit

Gravimetric vs label claim

100 mg labeled · 101.73 mg tested

Full credit

EndotoxinFull credit

USP <85> compendial

Pass (< 0.05 EU/mL)

Full credit

Heavy metalsFull credit

USP <232>/<233> compendial

Screened

Full credit

SterilityPartial

PCR / DNA microarray

Screened

Partial

Batch conformityPartial

Two-batch average

Assessed

Partial

Additional screens, not scoredFentanyl screen

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →